Affiliation:
1. Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA
Abstract
The validity of the Montreal Cognitive Assessment (MoCA) as a screen for mild cognitive impairment (MCI) and dementia was evaluated in African Americans attending an urban outpatient memory disorders clinic. Eighty one patients ≥50 years old were administered the MoCA and neuropsychological tests. Clinicians, blinded to the MoCA scores, reviewed the neuropsychological findings and reports of instrumental activities of daily living and they assigned a diagnosis of normal cognition (NC; N = 16), MCI (N = 38), or dementia (N = 27). The MoCA scores of the 3 groups were significantly different (NC > MCI > dementia). Using cutoff scores of ≤24 points for MCI and ≤22 points for dementia, the MoCA had .95 sensitivity and .63 specificity for MCI and .96 sensitivity and .88 specificity for dementia. The MoCA is a valid and cost-effective screen for cognitive impairment in African Americans but with a higher likelihood of falsely classifying persons with NC as having MCI.
Subject
Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Neurology
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Frequency and correlates of subjective cognitive complaints and objective cognitive screening results in African American adults following COVID-19 infection;Brain, Behavior, & Immunity - Health;2023-12
2. Subjective cognitive complaints in White and African American older adults: associations with demographic, mood, cognitive, and neuroimaging features;Aging, Neuropsychology, and Cognition;2023-08-21
3. Functional Connectivity Analysis of Visually Evoked ERPs for Mild Cognitive Impairment: Pilot Study;2023 45th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC);2023-07-24
4. Delirium and Behavioral Symptoms in Persons With Dementia at Hospital Admission;Alzheimer Disease & Associated Disorders;2023-03-13
5. Development of digital voice biomarkers and associations with cognition, cerebrospinal biomarkers, and neural representation in early Alzheimer's disease;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2023-01